Dermata Therapeutics Inc [NASDAQ: DRMA] traded at a high on Thursday, posting a 5.19 gain after which it closed the day’ session at $1.42.
The results of the trading session contributed to over 75951954 shares changing hands. Over the past one week, the price volatility of Dermata Therapeutics Inc stands at 21.91% while the volatility over the past one month is 10.24%.
The market cap for DRMA stock reached $7.71 million, with 5.43 million shares outstanding and 3.99 million shares in the current float. Compared to the average trading volume of 341.05K shares, DRMA reached a trading volume of 75951954 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Dermata Therapeutics Inc [DRMA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DRMA shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DRMA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Dermata Therapeutics Inc is set at 0.16 The Price to Book ratio for the last quarter was 2.29, with the Price to Cash per share for the same quarter was set at 0.58.
How has DRMA stock performed recently?
Dermata Therapeutics Inc [DRMA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.34. With this latest performance, DRMA shares gained by 19.33% in over the last four-week period, additionally sinking by -5.33% over the last 6 months – not to mention a drop of -77.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DRMA stock in for the last two-week period is set at 67.87, with the RSI for the last a single of trading hit 76.18, and the three-weeks RSI is set at 62.10 for Dermata Therapeutics Inc [DRMA]. The present Moving Average for the last 50 days of trading for this stock 1.2127, while it was recorded at 1.3320 for the last single week of trading, and 1.5967 for the last 200 days.
Dermata Therapeutics Inc [DRMA]: Deeper insight into the fundamentals
Dermata Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.79 and a Current Ratio set at 1.79.
Insider trade positions for Dermata Therapeutics Inc [DRMA]
There are presently around $0.84%, or 1.09%% of DRMA stock, in the hands of institutional investors.
